Identify Patients Who May Qualify for Meds to Prevent COVID-19 After Exposure

September 2021

You'll hear buzz about Regen-COV (casirivimab/imdevimab), the first med to PREVENT COVID-19...especially with cases on the rise.

This monoclonal antibody combo blocks the virus that causes COVID-19...SARS-CoV-2...from entering cells.

It's given as an IV infusion...or as 4 subcutaneous injections.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote